Codelists for: "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data"
Bidulka, P.
2024.
Codelists for: "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data".
[Online].
London School of Hygiene & Tropical Medicine, London, United Kingdom.
Available from:
https://doi.org/10.17037/DATA.00003743.
Bidulka, P.
Codelists for: "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data"
[Internet].
London School of Hygiene & Tropical Medicine;
2024.
Available from:
https://doi.org/10.17037/DATA.00003743.
Bidulka, P
(2024).
Codelists for: "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data".
[Data Collection].
London School of Hygiene & Tropical Medicine, London, United Kingdom.
https://doi.org/10.17037/DATA.00003743.
Description
Codelists to define index diagnosis, comorbidities, lifestyle risk factors, co-prescriptions, and outcomes for the PERsonalised Medicine for Intensification of Treatment (PERMIT) study manuscript titled "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data"
![[img]](https://datacompass.lshtm.ac.uk/style/images/fileicons/other.png)
